secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001193125-25-005042
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq Panel grants Minerva continued listing subject to equity compliance by March 31, 2025
--------------------------------------------------------------------------------

- Company must file disclosure on transactions to meet $2.5M minimum stockholders' equity by 3/31/25.
- Must also provide 12-month income projections with underlying assumptions to Panel by same deadline.
- Company is working toward compliance but states no assurance of regaining or maintaining listing.
- Original deficiency was market value below $35M; now equity compliance is the key condition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312525005042/0001193125-25-005042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312525005042/d906093d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-005042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer